|
Clinical characteristics
|
Number (n)
|
%
|
|---|
|
Total number
|
71
|
100
|
|
Age (years)
| | |
|
Median
|
59
| |
|
Range
|
29 - 75
| |
|
Gender
| | |
|
Male
|
48
|
68
|
|
Female
|
23
|
32
|
|
Disease stage
| | |
|
IIIA
|
66
|
93
|
|
IIIB
|
5
|
7
|
|
Tumor classification
| | |
|
T1
|
7
|
10
|
|
T2
|
43
|
60
|
|
T3
|
16
|
23
|
|
T4
|
5
|
7
|
|
Lymph node status
| | |
|
N2
|
71
|
100
|
|
Tumor location
| | |
|
Right upper lobe
|
28
|
39
|
|
Right middle lobe/central
|
5
|
7
|
|
Right lower lobe
|
9
|
13
|
|
Left upper lobe
|
16
|
23
|
|
Left lower lobe
|
13
|
18
|
|
Tumor histology
| | |
|
Squamous cell
|
25
|
35
|
|
Adenocarcinoma
|
41
|
58
|
|
Large cell
|
3
|
4
|
|
Other
|
2
|
3
|
|
Surgery type
| | |
|
Lobectomy
|
44
|
62
|
|
Bi-lobectomy
|
7
|
10
|
|
Pneumonectomy
|
20
|
28
|
|
Resection status
| | |
|
R0
|
53
|
75
|
|
R1
|
18
|
25
|
|
Resected lymph nodes
| | |
|
Median
|
33
| |
|
Range
|
10 – 60
| |
|
Chemotherapy
| | |
|
Induction
|
23
|
32
|
|
Adjuvant
|
48
|
68
|
|
RT dose (Gy)
| | |
|
Median
|
50
| |
|
Range
|
40 - 60
| |
